Skip to content
healthcare.dev

Labetalol Hydrochloride

NDC 68001-702, Labetalol Hydrochloride, tablet, from BluePoint Laboratories.

Product NDC
68001-702
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074787
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LABETALOL HYDROCHLORIDE300 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
68001-702-0068001070200100 TABLET in 1 BOTTLE (68001-702-00)
68001-702-0368001070203500 TABLET in 1 BOTTLE (68001-702-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e4562c70-f245-4dbe-8fe1-0bb64a91a315
  • NADAC price for package 68001070200

    GET /v1/drugs/nadac/68001070200
  • NADAC price for package 68001070203

    GET /v1/drugs/nadac/68001070203

Use it

Look up 68001-702 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.